The CCTS will host the acclaimed medical historian John M. Barry, author of "The Great Influenza: The Story of the Deadliest Pandemic in History," at the keynote panel of its 2021 Spring Research Days, to be held the afternoons of April 7 and 8.

The CCTS serves as the engine for UK's testing site of the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study ENSEMBLE 2, which is evaluating the safety and efficacy of a two-dose regimen of Janssen’s COVID-19 vaccine candidate.

The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, participated as a site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate.